BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 223 filers reported holding BLUEPRINT MEDICINES CORP in Q2 2019. The put-call ratio across all filers is 0.36 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $6,057,000 | +2118.7% | 91,922 | +1602.6% | 0.21% | +1675.0% |
| Q2 2022 | $273,000 | -28.3% | 5,399 | +31.4% | 0.01% | -52.0% |
| Q3 2020 | $381,000 | -61.9% | 4,109 | -68.0% | 0.02% | -64.3% |
| Q2 2020 | $1,001,000 | -50.3% | 12,838 | -62.7% | 0.07% | -52.1% |
| Q1 2020 | $2,013,000 | +763.9% | 34,423 | +1082.9% | 0.15% | +942.9% |
| Q4 2019 | $233,000 | +14.8% | 2,910 | +35.0% | 0.01% | -22.2% |
| Q2 2019 | $203,000 | -86.4% | 2,156 | -92.2% | 0.02% | -80.9% |
| Q4 2018 | $1,497,000 | -9.1% | 27,774 | +31.7% | 0.09% | -24.2% |
| Q3 2018 | $1,647,000 | -6.8% | 21,093 | +9.4% | 0.12% | +0.8% |
| Q1 2018 | $1,768,000 | +668.7% | 19,279 | +234.8% | 0.12% | +310.0% |
| Q1 2017 | $230,000 | -42.6% | 5,759 | -74.1% | 0.03% | -36.2% |
| Q1 2016 | $401,000 | -47.4% | 22,216 | -23.2% | 0.05% | -29.9% |
| Q4 2015 | $762,000 | – | 28,914 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 423,012 | $41,129,000 | 7.43% |
| Eagle Health Investments LP | 133,163 | $12,947,000 | 5.08% |
| DAFNA Capital Management LLC | 207,911 | $20,215,000 | 4.80% |
| Casdin Capital, LLC | 1,550,000 | $150,707,000 | 4.49% |
| SIB LLC | 65,151 | $6,335,000 | 3.72% |
| CADIAN CAPITAL MANAGEMENT, LP | 913,702 | $88,839,000 | 3.29% |
| Integral Health Asset Management, LLC | 117,500 | $11,425,000 | 3.26% |
| Rock Springs Capital Management LP | 746,732 | $72,605,000 | 1.58% |
| Avidity Partners Management LP | 546,000 | $53,088,000 | 1.47% |
| Zebra Capital Management LLC | 12,698 | $1,235,000 | 1.36% |